No photo of marco chiaravalli

marco chiaravalli

  • 0 Citations
  • 0 h-Index
20182018
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2018

2018

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Reni, M., Zanon, S., Balzano, G., Passoni, P., Pircher, C., Chiaravalli, M., Fugazza, C., Ceraulo, D., Nicoletti, R., Arcidiacono, PG., Macchini, M., Peretti, U., Castoldi, R., Doglioni, C., Falconi, M., Partelli, S. & Gianni, L., 2018, In : European Journal of Cancer. 102, p. 95-102 8 p.

Research output: Contribution to journal › Article

gemcitabine
Cisplatin
Adenocarcinoma
Disease-Free Survival
Survival

mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma

Drusian, L., Nigro, EA., Mannella, V., Pagliarini, R., Pema, M., Costa, ASH., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., Montorsi, F., Capitanio, U., Musco, G., Frezza, C. & Boletta, A., 2018, In : Cell Reports. 24, 5, p. 1093-1104.e6

Research output: Contribution to journal › Article

Fumarates
Renal Cell Carcinoma
Fumarate Hydratase
Up-Regulation
Cells